Regeneron Pharmaceuticals Statistics
NASDAQ: REGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
742.12+3.40 (+0.46%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Regeneron Pharmaceuticals by the numbers
Regeneron Pharmaceuticals has a market capitalization of $76.40 billion based on 101.14M shares outstanding. Its trailing P/E ratio is 18.4, below the 7-company peer median of 29.4, and its forward P/E is 12.1. The stock trades 5.8% below its 50-day average and 0.8% above its 200-day average.
Average daily trading volume is 741.47K shares, or about $550.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
REGN valuation vs. peer median
| Metric | REGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $76.40B | $37.11B | +106% |
| P/E (TTM) | 18.4 | 29.4 | -38% |
| Forward P/E | 12.1 | 10.9 | +10% |
| Dividend yield | 0.49% | 3.54% | -86% |
| Avg. volume | 741.47K | 2.90M | -74% |
Peer median across 8 companies: SNY, ONC, RPRX, BMY, ALNY, ZTS, ROIV, VRTX.
Valuation
- Market cap
- $76.40B
- P/E (TTM)
- 18.35
- Forward P/E
- 12.07
- Price / sales (latest FY)
- 5.33
- EPS (TTM)
- $40.44
- Shares outstanding
- 101.14M
Price and trading
- Previous close
- 738.72
- Open
- 738.05
- Day range
- 734.18 – 753.66
- 52-week range
- 541.00 – 859.34
- 52-week change
- +27.24%
- 50-day moving average
- 787.70
- 200-day moving average
- 735.89
- Beta
- —
- Volume
- 626.38K
- Average volume
- 741.47K
Dividends and events
- Annual dividend
- $3.64
- Dividend yield
- 0.49%
- Next earnings date
- Oct 30, 2026
Additional statistics
- Market Cap
- 76.40B
- Pe
- 18.35
- Forward Pe
- 12.07
- Eps
- 40.44
- Dividend Yield
- 51.00%
- Dividend Rate
- 3.64
- Week52 High
- 859.34
- Week52 Low
- 541.00
- Avg Volume
- 741.47K
- Shares Outstanding
- 101.14M
- Ma50
- 787.70
- Ma200
- 735.89
- Earnings Date
- Oct 30, 2026
- Pct From52w High
- -13.64%
- Pct From52w Low
- 37.18%